Valuation: Lifecare ASA

Market Cap 196M 20.4M 18.13M 16.9M 15.4M 28.87M 1.96B 29.32M 205M 79.4M 1B 76.58M 74.92M 3.21B P/E 2026 *
-1.37x
P/E 2027 * -3.01x
Enterprise Value 187M 19.46M 17.29M 16.13M 14.7M 27.54M 1.87B 27.97M 195M 75.76M 956M 73.07M 71.48M 3.06B EV / Sales 2026 *
187x
EV / Sales 2027 * -
Free-Float
71.12%
Yield 2026 *
-
Yield 2027 * -
1 day+4.57%
1 week+60.60%
Current month-15.61%
1 month+65.86%
3 months+65.86%
6 months+7.85%
Current year-85.25%
1 week 0.29
Extreme 0.288
0.84
1 month 0.28
Extreme 0.28
0.84
Current year 0.27
Extreme 0.27
1.99
1 year 0.27
Extreme 0.27
8.02
3 years 0.27
Extreme 0.27
82.16
5 years 0.27
Extreme 0.27
82.16
10 years 0.27
Extreme 0.27
117
Manager TitleAgeSince
Chief Executive Officer 50 2020-09-06
Director of Finance/CFO - 2026-03-31
Corporate Officer/Principal - 2024-02-29
Director TitleAgeSince
Director/Board Member - 2020-06-25
Chairman - 2021-05-07
Director/Board Member - 2020-11-19
Change 5-day change 1-year change 3-year change Capi.($)
+4.57%+60.60%-93.13%-98.99% 20.37M
+4.16%+3.04%+49.37%+94.17% 74.16B
-3.11%-3.53%+21.92%+74.60% 57.39B
+0.89%-0.63%+4.28%+34.51% 47.64B
+0.36%+0.81%+352.17%+689.61% 44.29B
-0.96%-4.50%+26.36%+33.18% 42.5B
-0.20%-0.77%+3.74%+100.60% 40.71B
-0.54%+2.93%+9.31%+50.41% 30.97B
-2.68%+2.92%+29.63%+19.50% 28.53B
+0.05%-1.64%-7.28%-14.06% 24.34B
Average +0.25%+5.53%+39.64%+98.35% 39.06B
Weighted average by Cap. +0.12%-0.84%+58.76%+129.90%

Financials

2026 *2027 *
Net sales 1M 104K 92.43K 86.18K 78.54K 147K 10.02M 149K 1.04M 405K 5.11M 391K 382K 16.34M -
Net income -109M -11.34M -10.07M -9.39M -8.56M -16.04M -1.09B -16.3M -114M -44.13M -557M -42.57M -41.64M -1.78B -67M -6.97M -6.19M -5.77M -5.26M -9.86M -671M -10.02M -69.88M -27.13M -342M -26.16M -25.6M -1.1B
Net Debt -9M -936K -832K -776K -707K -1.32M -90.15M -1.35M -9.39M -3.64M -45.97M -3.51M -3.44M -147M 4M 416K 370K 345K 314K 589K 40.07M 598K 4.17M 1.62M 20.43M 1.56M 1.53M 65.38M
Logo Lifecare ASA
Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
Employees
11
Date Price Change Volume
26-10-02 NOK 0.4810 +4.57% 39,956,182
26-10-01 NOK 0.4600 -19.30% 71,625,170
26-09-30 NOK 0.5700 +3.26% 157,229,545
26-09-29 NOK 0.5520 +88.72% 114,287,421
26-09-28 NOK 0.2925 -2.34% 1,750,358

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LIFE Stock